After decades of frustrated research efforts, enthusiasm is rising for early-stage clinical work to develop drugs that target a genetic mutation known as KRAS, an...

Living a healthy lifestyle may help offset a person's genetic risk of dementia, according to new research. The study was led by the University of Exeter - simultaneo...

Roche showed off additional efficacy and safety data for fast-growing hemophilia A drug Hemlibra. (Roche) Roche’s Hemlibra has been growing at eye-catching spee...

England's National Institute for Health and Care Excellence has decided to back Alnylam's gene-silencing therapy Onpattro, following a thumbs-up to Ionis' rival med...

Credit: GSK via Flickr ViiV Healthcare, an HIV drugmaker majority owned by GlaxoSmithKline, released clinical data Wednesday showing its two-drug therapy was abl...

Whether Array is worth $11 billion for Pfizer is dependent on whether both Braftovi and Mektovi are needed in colorectal cancer. (Array BioPharma) One key incent...

Amarin will double its sales force for fish-oil derivative Vascepa on the back of a record six months of sales. (Pixabay) Amarin has been teasing big plans ...